Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study PXN110448: A Dose-response Study of XP13512, Compared With Concurrent Placebo Control and LYRICA(Pregabalin), in Subjects With Neuropathic Pain Associated Withdiabetic Peripheral Neuropathy (DPN)

NCT00643760 is registered in ClinicalTrials.gov with XenoPort, Inc. as lead sponsor.

NCT NCT00643760
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00643760 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study PXN110448: A Dose-response Study of XP13512, Compared With Concurrent Placebo Control and LYRICA(Pregabalin), in Subjects With Neuropathic Pain Associated Withdiabetic Peripheral Neuropathy (DPN)
Lead sponsor
XenoPort, Inc.
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2008
Completion date
February 28, 2009
Enrollment
421 (actual)
Sites
90

Conditions

As the registry lists them; a condition with its own page is linked.

neuropathy, diabetic